CS Paper Radar

Does Country Matter? Evaluating Geographic Sensitivity of Large Language Models in Zero-Shot Chronic Kidney Disease Screening

Sirajam Munira, Muhammad Ashad Kabir

cs.LG ·submitted 2026-09-16 03:48 UTC · v1
published

Abstract

Large language models (LLMs) show strong zero-shot reasoning capabilities, yet their sensitivity to prompt context raises questions about reliability in deployment. This study investigates whether geographic context embedded in prompts influences LLM-based chronic kidney disease (CKD) screening, independent of any change in patient features. Using a community-based CKD dataset from Bangladesh (284 participants with 112 CKD and 172 non-CKD), we systematically varied the country attribute across 25 global contexts while holding all clinical inputs constant, and evaluated two open-weight LLMs (Qwen3 8B and Mistral 7B). Experiments were conducted on a common-correct subset of 156 participants for whom both models produced correct baseline predictions. Results show that non-CKD predictions were highly stable across geographic contexts, with both models maintaining consistent non-CKD predictions in nearly all settings. In contrast, CKD-positive predictions were considerably more sensitive. For Qwen3, CKD prediction dropped from a baseline of 65 to as low as 50 across country contexts, while Mistral showed smaller but non-negligible variation. Country contexts did not group according to known epidemiological or healthcare similarities; instead, groupings appear to reflect how country tokens are internally represented within each model. These findings demonstrate that geographic tokens can systematically shift clinical screening outcomes despite identical patient inputs, with implications for the deployment of LLM-based decision support in diverse healthcare settings.

Comment
Accepted to ACM HIKM-2026, 13 pages, 2 figures

Closest papers

Nearest neighbours by meaning across the whole index.

LLM4CKD: Large Language Models for Early Stage Chronic Kidney Disease Screening

cs.AI cs.LG ·2026-09-03 ·Muhammad Ashad Kabir, Sirajam Munira
top venuecode/data similarity 0.71
Abstract · Accepted at ICDM 2026

Early screening of chronic kidney disease (CKD) is critical for timely intervention, yet most machine learning (ML) and deep learning (DL) approaches require labeled data and model training, limiting their use in real-world screening settings. This study evaluates the effectiveness of large language models (LLMs) for CKD screening under zero-shot and few-shot in-context learning settings and compares them with traditional ML and DL methods. We propose a framework that uses clinically selected tabular features and structured prompt templates to enable LLM-based inference without task-specific training. LLM performance is evaluated across multiple prompt styles, feature configurations, and data settings, and compared with standard ML, DL, and tabular foundation model (TFM) baselines, and existing CKD screening tools. The results show that LLMs can achieve competitive performance using only a small number of examples, often matching or outperforming traditional approaches in low-data settings. However, their performance remains model-dependent and less stable as input complexity increases. In contrast, ML, DL, and TFM models show more consistent improvement with larger training data. Overall, the findings highlight a trade-off between data efficiency and stability, suggesting that LLMs may serve as a flexible complementary approach for CKD screening when labeled data are limited. To facilitate further research and reproducibility, the code has been made publicly available at https://github.com/akabircs/LLM4CKD

0.45

TCMClinicalReason-Bench: Can Language Models Reason from Pathogenesis to Prescription over Real-World Clinical Cases?

cs.AI ·2026-10-03 ·Jirui Dai, Chenkai Zhang, Yan Jia, Yukai Wang, Ruiyang He +2 more
similarity 0.60
Abstract

Large language models (LLMs) can generate clinical narratives that are insufficiently grounded in patient-specific evidence. In traditional Chinese medicine (TCM), errors can propagate from etiology and pathogenesis through syndrome diagnosis and treatment principles to prescription generation. We developed TCMClinicalReason-Bench using 2,000 multicenter electronic health record cases to distinguish case-grounded responses from fluent but unsupported diagnostic and therapeutic conclusions. Five general-purpose and two TCM-specific LLMs were evaluated in zero-shot settings. An evidence-constrained rubric assessed seven diagnostic and therapeutic components and three cross-block relations, allowing case-supported alternatives. Qwen3.7-Plus with TCM retrieval served as the automated judge, alongside parallel blinded ratings by five senior TCM clinicians on a 600-case subset. Structural completeness was nearly saturated (99.3-100.0%), but normalized content scores ranged from 40.7% to 54.1%. The five general-purpose models averaged 50.0%, versus 41.3% for the two smaller TCM-specific models. Cross-block logic consistency ranged from 60.8% to 66.8% and correlated moderately with content across cases (Pearson's r = 0.515-0.656). Deficits were greatest in prescription generation, prescription analysis, and symptom-guided modification. In judge stress testing on 100 independent cases, perturbation detection rates across the three relations were 57%, 56%, and 31%, with contradictions detected more reliably than omissions. Separating component quality from cross-block consistency localizes failures missed by endpoint and completeness metrics and identifies where clinician oversight remains necessary.

0.18

The widening evaluation gap in medical large language model research 2023 to 2026

cs.CL ·2026-09-10 ·Raad Bin Tareaf, Murad Al-Rajab, Samia Loucif
similarity 0.57
Abstract

Large language models are superseded every few quarters; clinical evidence takes years. We asked whether medical research is keeping pace with the systems it evaluates. PubMed returned 11,628 records for January 2023 to June 2026 across fourteen clinical domains, growing 45-fold; 2.5% used a randomised, controlled or prospective design. Evaluation lag, from a study's newest named model release to its own publication, widened from 1.33 to 6.08 quarters. Because discontinued models age mechanically, we benchmarked this against a counterfactual holding model composition fixed: migration to newer systems offset only 56% of the drift (95% CI 50-65). Randomised trials evaluated models a median 4.6 quarters older than other designs (P = 3 x 10^-19), yet among studies naming a model still under development no design differed from any other; 62% of randomised trials evaluated a discontinued family. Rigour and currency are in tension, and that tension reflects model selection rather than research timelines.

0.26

Demographic Injection in Medical Language Models under Diversity, Equity, and Inclusion Prompts

cs.AI cs.CL ·2026-08-15 ·Diego Mardian, Frank Liu
similarity 0.57
Abstract

Clinical-AI guidance increasingly recommends prompting language models to reason with attention to diversity, equity, and inclusion (DEI). We measure a side effect that misrepresents patients: a one-sentence DEI prompt appended to a medical question leads models to add patient demographic attributes (race, socioeconomic status, sex) the question never stated, in effect rewriting who the patient is. We call this demographic injection. Across 47 models, four medical benchmarks, and 376,000 responses scored by a validated model-judge pipeline, a single DEI prompt raises the injection rate from 0.7% to 33.1% (47x) in all 47 of 47 models, attributable to the equity content rather than to added length (18x above a length-matched control; p=1.4x10^-14). Most added content is a general population statement that leaves the answer unchanged, but a smaller subset attaches an attribute to the specific patient or changes the selected option (0.25-2.4% of responses, 99.8% toward the incorrect option), where the invented demographic changes the answer the model recommends. Phrasing scales the effect from 14% to 56%. DEI prompts are just one example of a more general mechanism. Any instruction that nudges how a model reasons can make it add unrequested details, including details about the patient. Flagged outputs are treated as model errors under study, not clinical guidance.

0.04

What Language Adds, and at What Cost: Four Controlled Probes of Pathology Vision-Language Models

cs.CV q-bio.QM ·2026-10-19 ·Wenhao Zhang, Zhongliang Zhou, Yi Ping, Zirui Wang, Sheng Li
similarity 0.56
Abstract

Vision--language models (VLMs) promise to make computational pathology queryable and able to draft reports, but how much language adds beyond the vision backbone is unclear, because almost every system is evaluated by its developers on test sets of their own choosing. We grade published evidence by how it was produced and test four claims with controlled probes that reuse released checkpoints and public data, varying one input at a time. Report text adds prognostic signal: adding a frozen embedding of the stage-redacted report to a slide embedding raises the pooled C-index by 0.019 for progression-free interval and by 0.016 for overall survival across 1{,}633 TCGA patients, and restoring the stage statement adds nothing. Prompts add no measurable accuracy at inference: with features and pooling fixed, zero-shot classification is statistically indistinguishable from a supervised linear probe for lung and renal cancer subtyping. Slide-level question answering is barely grounded: SlideChat answers 74.82\% of SlideBench-VQA(TCGA) items correctly with the slide and 74.41\% without it, whereas its language backbone alone reaches 43.52\%. Paraphrasing leaves accuracy unchanged but flips 8--23\% of answers. Self-reported gains from agentic navigation and few-shot language priors cannot yet be attributed to language. Language thus adds real but narrow value, and we propose minimum controls that would expose these failure modes in future evaluations.

0.18

Being judged through the record: A Rosenhan-inspired test of psychiatric label sensitivity in large language models

cs.CY ·2026-10-26 ·Shaked Rosenblum, Teddy Lazebnik, Ziv Ben-Zion
similarity 0.56
Abstract

The integration of large language models (LLMs) into clinical decision-making raises unresolved questions regarding diagnostic bias. We investigate whether a documented psychiatric history alters LLM recommendations when the current clinical evidence is identical. Using a counterfactual experiment inspired by Rosenhan's 1973 field study, we factorially varied diagnostic-history condition (no prior diagnosis stated vs. prior schizophrenia diagnosis) and current-evidence condition (voices ceased vs. voices persisted) within a clinical vignette. Across five LLMs (GPT-5.6 Sol, Claude Sonnet 5, Gemini 3.6 Flash, Grok 4.6, and Mistral Large 2512), we generated 20,000 model responses across independent queries. When evidence supported discharge, adding a prior schizophrenia diagnosis increased recommendations for continued hospitalization nearly fivefold, from 4.7% to 22.3% (risk difference, 17.5 percentage points; 95% CI, 16.2-18.8). This shift occurred across all five models (risk-difference range, 10.4-34.4 percentage points). In the same condition, reference concordance decreased from 95.3% to 77.7%, while stated decision confidence increased. Across all model-by-evidence contrasts, confidence increases corresponded to Cohen's d values of 0.35-1.09. Signal-detection analyses showed that the prior diagnosis shifted the decision criterion toward hospitalization across all five models and reduced discrimination between the two current-evidence conditions in three of them. When current evidence supported continued hospitalization, the label increased the recommendation for hospitalization from 92.6% to 97.0%.

0.17

Large language model-generated patterns for epidemiological modeling: a multi-benchmark evaluation framework

cs.AI ·2026-10-11 ·Sophia Mao, Keshav Gandhi, Alexander Gutfraind
benchmark similarity 0.56
Abstract

Representing individual-level behavioral heterogeneity is challenging in epidemiological modeling, particularly when empirical behavioral data are sparse. We assess the potential of large language model (LLM)-generated behavioral outputs in addressing this challenge, using hepatitis C virus-related behaviors among people who inject drugs as a case study. Correspondence with epidemiological patterns was evaluated using external benchmarks: literature-informed association directions, correlations from an agent-based model (ABM), and survey associations. Across three LLMs, unconditional directional recovery across 28 retained literature-informed associations was 46-68%, compared with 82-93% agreement when LLMs were directly asked to classify the same associations. Mean absolute differences from ABM and survey correlation patterns were 0.11-0.13 and 0.15-0.18, respectively. Together, these findings show partial alignment between LLM-generated behavioral relationships and epidemiological evidence, despite higher knowledge-probe agreement. More systematic evaluation is needed before incorporating LLM-generated behavioral outputs into epidemiological models that simulate transmission dynamics.

0.24

AusClinBench: a deterministically scored benchmark of large language models against current Australian clinical policy

cs.CY cs.CL ·2026-10-22 ·Daniel S. Epstein
benchmarkhot direction similarity 0.55
Abstract · 19 pages, 3 figures. Technical report, version 1.4.1 of the benchmark. Not peer reviewed. Answer keys not yet independently reviewed. Result…

AI models already inform clinical decisions and draft notes in Australian clinical software, usually without the practitioner being told which model is used. Existing medical benchmarks are written for other jurisdictions. We wrote 142 questions from Australian guidelines and schedules across five domains (PBS authority, MBS billing, Ahpra obligations, triage red flags, immunisation and screening), each with one verifiable answer scored by exact match. Each question ran blind and with the governing clause supplied, which separates failure to recall the current rule from failure to apply it. We tested 28 models between July and October 2026. Blind accuracy ranged from 51.5% to 92.7%, and the highest-scoring models could not be separated. Of 791 failed model-question pairs, 684 (86%) were wrong blind and right with the clause. Confident-error rates ranged from 6.6% to 47.8%. On five immunisation questions where the guideline gives no directive, 82% of answers stated one. On 20 Aboriginal and Torres Strait Islander health questions, models did no worse overall, but on a few the wrong answers gave the rule for the general population, an older rule or another country's rule. We propose treating the model as an ingredient of a clinical product, with a minimum standard on local rules that sits beside product evaluation. The keys are one general practitioner's and are not yet independently reviewed. The benchmark measures base models, not clinical products, and does not license any model for clinical use.

0.35